Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at CHF 22.6B, ahead of Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B). Figures as of 18 Nov 2026, 15:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonCHF 22.6B
- Median
- CHF 49.7M
- Combined market value
- CHF 4.31T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CHF 22.6B | CHF 560.9B | CHF 233.01 | 0.80% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | CHF 17.4B | CHF 1.05T | CHF 1,180.40 | 1.06% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | CHF 15.4B | CHF 292.6B | CHF 118.70 | 1.76% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | CHF 12.8B | CHF 148.9B | CHF 33.78 | 1.53% down | 17% down | ||
| 5 | NovartisNVS · Health Care | CHF 11.8B | CHF 249.5B | CHF 132.09 | 1.51% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | CHF 8.6B | CHF 235B | CHF 151.55 | 1.34% down | 2% up | ||
| 7 | SanofiSNY · Health Care | CHF 7.3B | CHF 96B | CHF 39.97 | 0.22% down | 4% down | ||
| 8 | PfizerPFE · Health Care | CHF 6.5B | CHF 136B | CHF 23.86 | 0.54% down | 14% up | ||
| 9 | GSKGSK · Health Care | CHF 6.4B | CHF 82.9B | CHF 41.37 | 0.30% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | CHF 5.9B | CHF 103.9B | CHF 50.85 | 1.65% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | CHF 5.5B | CHF 152.7B | CHF 88.15 | 0.11% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | CHF 3.8B | CHF 84B | CHF 812.45 | 0.65% up | 36% up | ||
| 13 | AbbVieABBV · Health Care | CHF 3.6B | CHF 431.5B | CHF 244.10 | 1.09% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | CHF 3.3B | CHF 115.1B | CHF 453.88 | 0.81% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | CHF 2.3B | CHF 28.6B | CHF 70.49 | 0.19% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 1.2B | CHF 41.8B | CHF 35.85 | 0.19% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | CHF 1.1B | CHF 20.7B | CHF 486.75 | 1.12% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | CHF 811.6M | CHF 26.9B | CHF 43.58 | 0.47% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | CHF 649.7M | CHF 33.3B | CHF 57.86 | 0.04% down | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | CHF 575.3M | CHF 4.3B | CHF 51.13 | 0.51% up | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 384.3M | CHF 10.5B | CHF 12.65 | 1.39% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | CHF 376.9M | CHF 8.1B | CHF 53.56 | 1.34% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | CHF 375.9M | CHF 4.9B | CHF 7.23 | 0.63% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | CHF 294.1M | CHF 9.8B | CHF 50.37 | 2.15% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | CHF 264.4M | CHF 17.5B | CHF 130.56 | 1.02% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | CHF 241.8M | CHF 39.2B | CHF 342.90 | 1.55% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | CHF 203.7M | CHF 6.5B | CHF 38.84 | 1.40% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | CHF 104.9M | CHF 5B | CHF 251.71 | 1.65% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | CHF 84M | CHF 6.4B | CHF 58.73 | 0.54% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | CHF 60.7M | CHF 6.3B | CHF 18.13 | 1.85% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 49.7M | CHF 6.4B | CHF 81.34 | 1.47% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -CHF 1.4M | CHF 5.2B | CHF 36.84 | 1.67% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -CHF 19.7M | CHF 5B | CHF 77.19 | 0.39% down | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -CHF 21.5M | CHF 4.1B | CHF 42.61 | 1.06% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -CHF 59M | CHF 4.5B | CHF 106.54 | 0.61% up | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -CHF 65.4M | CHF 5.4B | CHF 133.68 | 0.57% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -CHF 88.9M | CHF 5.6B | CHF 82.45 | 1.57% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -CHF 105M | CHF 4B | CHF 11.37 | 2.84% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -CHF 109.7M | CHF 7B | CHF 107.01 | 1.84% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -CHF 130.8M | CHF 7.7B | CHF 80.78 | 2.17% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -CHF 136.8M | CHF 4.1B | CHF 73.69 | 0.52% up | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -CHF 141.4M | CHF 3.8B | CHF 35.10 | 0.93% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -CHF 154.4M | CHF 6B | CHF 113.48 | 0.96% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -CHF 154.9M | CHF 3.4B | CHF 24.69 | 0.31% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -CHF 165.6M | CHF 6.9B | CHF 98.84 | 0.57% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -CHF 195.5M | CHF 11.1B | CHF 22.19 | 1.88% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -CHF 213.2M | CHF 14.9B | CHF 227.09 | 0.64% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -CHF 243M | CHF 8.2B | CHF 350.94 | 1.32% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -CHF 250.1M | CHF 2.7B | CHF 13.77 | 1.40% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -CHF 252.6M | CHF 23.8B | CHF 32.82 | 0.59% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -CHF 255.6M | CHF 7.3B | CHF 259.86 | 1.07% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -CHF 277.2M | CHF 4.2B | CHF 24.15 | 2.91% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -CHF 300.2M | CHF 13.1B | CHF 204.81 | 0.96% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -CHF 314.3M | CHF 6.2B | CHF 70.83 | 2.36% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -CHF 321.4M | CHF 3.8B | CHF 22.79 | 0.30% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -CHF 617.7M | CHF 12.7B | CHF 65.43 | 1.09% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -CHF 661.6M | CHF 6.1B | CHF 43.99 | 1.05% up | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -CHF 804.4M | CHF 57.8B | CHF 18.09 | 0.80% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -CHF 909.9M | CHF 7.5B | CHF 9.37 | 4.22% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -CHF 1.1B | CHF 22.4B | CHF 102.03 | 0.65% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -CHF 3B | CHF 19.9B | CHF 17.38 | 0.83% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8428 CHF).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (CHF 22.6B), Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 15:14 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of CHF 4.31T as of 18 Nov 2026, 15:14 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.